ABC | Volume 113, Nº5, November 2019

Guidelines Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology – 2019 Arq Bras Cardiol. 2019; 113(5):1006-1056 agudo domiocárdio com supradesnivelamento do segmento ST. J Transcat Intervent. 2018 Aug;26:1-6 143. Marino BC, Ribeiro AL, Alkmim MB, Antunes AP, Boersma E, Marcolino MS. Coordinated regional care of myocardial infarction in a rural area in Brazil: Minas Telecardio Project 2. Eur Heart J Qual Care Clin Outcomes. 2016;2(3):215-24 144. Caluza AC, Barbosa AH, Goncalves I, Oliveira CA, Matos LN, Zeefried C, et al. ST-Elevation myocardial infarction network: systematization in 205 cases reduced clinical events in the public health care system. Arq Bras Cardiol. 2012;99(5):1040-8 145. Filgueiras Filho NM, Feitosa Filho GS, Solla DJF, Arg lo FC, Guimarães PO, Paiva Filho IM, et al. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST). J Am Heart Assoc. 2018;7(14). pii: e008624 146. Brasen CL, Madsen JS, Parkner T, Brandslund I. Home Management of Warfarin Treatment Through a Real-Time Supervised Telemedicine Solution: A Randomized Controlled Trial. Telemed J E Health. 2019;25(2):109-15 147. PozziM,MitchellJ,HenaineAM,HannaN,SafiO,HenaineR.International normalized ratio self-testing and self-management: improving patient outcomes. Vasc Health Risk Manag. 2016 Oct;12:387-92 148. Heneghan CJ, Garcia-Alamino JM, Spencer EA, Ward AM, Perera R, Bankhead C, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2016 Jul;7:CD003839 149. SaiaM, MantoanD, FonzoM, Bertoncello C, SoattinM, SperottoM, et al. Impact of the Regional Network for AMI in the Management of STEMI on Care Processes, Outcomes and Health Inequities in the Veneto Region, Italy. Int J Environ Res Public Health. 2018;15(9). pii: E1980 150. Beatty AL, Fukuoka Y, WhooleyMA. Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J AmHeart Assoc. 2013;2(6):e000568 151. Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R. Telehealth exercise-based cardiac rehabilitation: a systematic review and meta- analysis. Heart. 2016;102(15):1183-92 152. Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, et al. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation ProgramWith Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. J Med Internet Res. 2015;17(7):e185 153. Peng X, Su Y, Hu Z, Sun X, Li X, DolanskyMA, et al. Home-based telehealth exercise training program in Chinese patients with heart failure: A randomized controlled trial. Medicine (Baltimore). 2018;97(35):e12069 154. Maddison R, Rawstorn JC, Stewart RAH, Benatar J, Whittaker R, Rolleston A, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial. Heart. 2019;105(2):122-9 155. Taylor RS, Dalal H, Jolly K, Moxham T, Zawada A. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2010(1):CD007130 156. Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, et al. Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis. Eur J Prev Cardiol. 2016;23(7):674-82 157. Lopez-Villegas A, Catalan-Matamoros D, Martin-Saborido C, Villegas- Tripiana I, Robles-Musso E. A Systematic Review of Economic Evaluations of Pacemaker Telemonitoring Systems. Rev Esp Cardiol (Engl Ed). 2016;69(2):125-33 158. Bourge RC, AbrahamWT, Adamson PB, AaronMF, Aranda JM Jr, Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS HF study. J Am Coll Cardiol. 2008;51(11):1073-9 159. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583-90 160. De Simone A, Leoni L, Luzi M, Amellone C, Stabile G, La Rocca V, et al. Remotemonitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace. 2015;17(8):1267-75 161. Kurek A, Tajstra M, Gadula-Gacek E, Buchta P, Skrzypek M, Pyka L, et al. Impact of remote monitoring on long-term prognosis in heart failure patients in a real-world cohort: results from all-comers COMMITHF trial. J Cardiovasc Electrophysiol. 2017;28(4):425-31 162. Klersy C, Boriani G, De Silvestri A, Mairesse GH, Braunschweig F, Scotti V, et al. Effect of telemonitoring of cardiac implantable electronic devices on health care utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. 2016;18(2):195-204 163. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. PacingClin. Electrophysiol. 2007;30(Suppl1):S2-12 164. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoringtechnology improves detection and clinical management of atrial fibrillation. Europace. 2009;11(1):54-61 165. Ricci RP, Morichelli L, D’Onofrio A, Calo L, Vaccari D, Zanotto G, et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the Home Guide Registry. Europace. 2013;15(7):970-7 166. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660-8 167. Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017;136(19):1784-94 168. Bruining N, Caiani E, Chronaki C, Guzik P, van der Velde E. Acquisition and analysis of cardiovascular signals on smartphones: potential, pitfalls and perspectives: by the Task Force of the e-Cardiology Working Group of European Society of Cardiology. Eur J Prev Cardiol. 2014;21(2 Suppl):4-13 169. Bilgi M, Gulalp B, Erol T, GulluH, KaragunO, Altay H, et al. Interpretation of electrocardiogram images sent through the mobile phone multimedia messaging service. Telemed J E Health. 2012;18(2):126-31 170. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167-76 171. Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017;136(19):1784-1794 172. Zungsontiporn N, Link MS. Newer technologies for detection of atrial fibrillation. BMJ. 2018 Oct;363:k3946 173. StanfordMedicine.AppleHeartStudy. [acessoem04set2019].Disponível em: https://med.stanford.edu/appleheartstudy.html 174. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al.2012 ACCF/AHA/HRS focused update incorporated into the ACCF/ AHA/HRS2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the AmericanCollege of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75 1050